ANA
LLUCH HERNANDEZ
EMÉRITO/A UNIVERSIDAD
Antonio
Casado Herráez
Publicaciones en las que colabora con Antonio Casado Herráez (11)
2018
-
Correction to: Persistent major alopecia following adjuvant docetaxel for breast cancer: incidence, characteristics, and prevention with scalp cooling (Breast Cancer Research and Treatment, (2018), 171, 3, (627-634), 10.1007/s10549-018-4855-2)
Breast Cancer Research and Treatment
-
Persistent major alopecia following adjuvant docetaxel for breast cancer: incidence, characteristics, and prevention with scalp cooling
Breast Cancer Research and Treatment, Vol. 171, Núm. 3, pp. 627-634
2010
-
Phase I study of oral vinorelbine and capecitabine in patients with metastatic breast cancer
Anticancer Research, Vol. 30, Núm. 6, pp. 2255-2261
2003
-
Phase II study of pemetrexed in breast cancer patients pretreated with anthracyclines
Annals of Oncology, Vol. 14, Núm. 8, pp. 1246-1252
2000
-
Circulating HER2 extracellular domain and resistance to chemotherapy in advanced breast cancer
Clinical Cancer Research, Vol. 6, Núm. 6, pp. 2356-2362
-
Doxorubicin and paclitaxel in advanced breast carcinoma: Importance of prior adjuvant anthracycline therapy
Cancer, Vol. 89, Núm. 11, pp. 2169-2175
-
Paclitaxel plus vinorelbine: An active regimen in metastatic breast cancer patients with prior anthracycline exposure
Annals of Oncology, Vol. 11, Núm. 1, pp. 85-89
1998
-
Preliminary Results of a Phase II Study: Paclitaxel Plus Vinorelbine in Metastatic Breast Ca Patients with Contraindications to Receive Anthracyclines
ONCOLOGY, Vol. 12, Núm. 1 SUPPL.1, pp. 28-30
1994
-
Clinical activity of chronic oral etoposide in previously treated metastatic breast cancer
Journal of Clinical Oncology, Vol. 12, Núm. 5, pp. 986-991
-
Phase II trial of weekly IV vinorelbine in first-line advanced breast cancer chemotherapy
Annals of Oncology, Vol. 5, Núm. 9, pp. 854-857
1993
-
Preliminary results of a phase II trial of chronic oral etoposide in breast cancer
Cancer Treatment Reviews, Vol. 19, Núm. SUPPL. C, pp. 47-52